Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Testicular diseases and treatments, and Renal and related cancers.
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types
'BJUI Clinical Dilemma': the incidental small renal mass in a solitary kidney.
What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An International Neoadjuvant Kidney Cancer Consortium Delphi study.
Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancer.
Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy.
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
Cytoreductive nephrectomy and exposure to sunitinib – a <i>post hoc</i> analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
Required efficacy for novel therapies in BCG-unresponsive non-muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?
Abstract B23: <i>FGFR3</i> mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell–Cell Communication in Renal Cell Carcinoma
Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma
Initial results from ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial.
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma
Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
Active Surveillance Is the Preferred Approach to Clinical Stage I Testicular Cancer
Rationale for Percutaneous Biopsy and Histologic Characterisation of Renal Tumours
Collaborative Research: Cell-free glycoprotein synthesis technology for point-of-care vaccine biomanufacturing
Collaborative Research: Cell-free glycoprotein synthesis technology for point-of-care vaccine biomanufacturing
Cell-Free Systems Conference
Collaborative Research: Repurposing the translation apparatus for mirror image polypeptide synthesis
Synthetic Biology, Engineering, Evolution & Design 2016 (SEED 2016), Chicago, IL, July 18-21, 2016
Collaborative Research: Glycoengineering Without Borders: Bacterial Cell-Free Glycoprotein Synthesis
Materials World Network: Chemical and BIological Approaches to Sequence Controlled Polymers
Collaborative Research: Engineering Genetically Augmented Polymers (GAPS)
International Research Fellowship Program: Systems Biology of Glucose Repression in Yeast for Metabolic Engineering